Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)

Saved in:
Bibliographic Details
Published in:Dermatology and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868554018066792448
collection WordPress RSS
FRELIP Feed Integration
container_title Dermatology and Therapy
description
discipline_display Dermatology and Venereology
discipline_facet Dermatology and Venereology
format Online Article
RSS Article
genre Journal Article
id rss_article:93961
institution FRELIP
journal_source_facet Dermatology and Therapy
last_indexed 2026-06-20T21:45:54.952Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
Dermatology and Venereology
General
Dermatology and Venereology
sub_discipline_display General
sub_discipline_facet General
subject_display Dermatology and Venereology
General
Dermatology and Venereology
subject_facet Dermatology and Venereology
General
Dermatology and Venereology
title Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
title_alt Eficacia y seguridad a tres años de lebrikizumab en pacientes con dermatitis atópica moderada a grave: una extensión a largo plazo (ADjoin)
Efficacité et sécurité à trois ans du lébrikizumab chez les patients atteints de dermatite atopique modérée à sévère : une extension à long terme (ADjoin)
Eficácia e Segurança de Lebrikizumabe em Três Anos em Pacientes com Dermatite Atópica Moderada a Grave: Uma Extensão de Longo Prazo (ADjoin)
title_auth Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
title_es_txt Eficacia y seguridad a tres años de lebrikizumab en pacientes con dermatitis atópica moderada a grave: una extensión a largo plazo (ADjoin)
title_fr_txt Efficacité et sécurité à trois ans du lébrikizumab chez les patients atteints de dermatite atopique modérée à sévère : une extension à long terme (ADjoin)
title_full Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
title_fullStr Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
title_full_unstemmed Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
title_pt_txt Eficácia e Segurança de Lebrikizumabe em Três Anos em Pacientes com Dermatite Atópica Moderada a Grave: Uma Extensão de Longo Prazo (ADjoin)
title_short Three-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin)
title_sort three-year efficacy and safety of lebrikizumab in patients with moderate-to-severe atopic dermatitis: a long-term extension (adjoin)
topic Dermatology and Venereology
General
Dermatology and Venereology
url https://link.springer.com/article/10.1007/s13555-026-01810-1